Related references
Note: Only part of the references are listed.Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 20002004
Candace H. Feldman et al.
ARTHRITIS AND RHEUMATISM (2013)
Efficacy and Safety of Rituximab in Patients With Active Proliferative Lupus Nephritis The Lupus Nephritis Assessment With Rituximab Study
Brad H. Rovin et al.
ARTHRITIS AND RHEUMATISM (2012)
Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts
Candido Diaz-Lagares et al.
AUTOIMMUNITY REVIEWS (2012)
Rituximab induces a rapid and sustained remission in Colombian patients with severe and refractory systemic lupus erythematosus
L. F. Pinto et al.
LUPUS (2011)
MECHANISMS OF DISEASE Systemic Lupus Erythematosus
George C. Tsokos
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Safety and Efficacy of Rituximab in Systemic Lupus Erythematosus
Benjamin Terrier et al.
ARTHRITIS AND RHEUMATISM (2010)
Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial
Joan T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Use of rituximab in the treatment of refractory systemic lupus erythematosus: Singapore experience
A. Lateef et al.
LUPUS (2010)
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Gerald B. Appel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
European consensus statement on the terminology used in the management of lupus glomerulonephritis
C. Gordon et al.
LUPUS (2009)
Rituximab in systemic lupus erythematosus A systematic review of off-label use in 188 cases
M. Ramos-Casals et al.
LUPUS (2009)
Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis
Iva Gunnarsson et al.
ARTHRITIS AND RHEUMATISM (2007)
CD20: A target antigen for immunotherapy of autoimmune diseases
F Perosa et al.
AUTOIMMUNITY REVIEWS (2005)
The classification of glomerulonephritis in systemic lupus erythematosus revisited
JJ Weening et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Immunosuppressive therapy in lupus nephritis -: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide
FA Houssiau et al.
ARTHRITIS AND RHEUMATISM (2002)
Share Paper
